Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
30.34
0.58 (1.95%)
At close: Aug 19, 2025, 3:59 PM
30.33
-0.05%
After-hours: Aug 19, 2025, 04:25 PM EDT

Amphastar Pharmaceuticals Revenue

Amphastar Pharmaceuticals reported an annual revenue of $712.81M, reflecting a 10.62% growth. For the quarter ending June 30, 2025, Amphastar Pharmaceuticals generated $174.41M in revenue.
Revenue (ttm)
712.81M
Revenue Growth
10.62%
Price / Sales Ratio
2.52
Revenue / Employee
351.49K
Employees
2,028
Market Cap
1.41B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 712.81M +10.62%
Dec 31, 2023 644.39M +29.14%
Dec 31, 2022 498.99M +13.98%
Dec 31, 2021 437.77M +25.13%
Dec 31, 2020 349.85M +8.53%
Dec 31, 2019 322.36M +9.40%
Dec 31, 2018 294.67M +22.69%
Dec 31, 2017 240.18M -5.87%
Dec 31, 2016 255.16M +1.45%
Dec 31, 2015 251.52M +19.51%
Dec 31, 2014 210.46M -8.37%
Dec 31, 2013 229.68M +12.41%
Dec 31, 2012 204.32M +72.63%
Dec 31, 2011 118.36M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.